Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.5800 (4.38%) ($98.1100 - $101.9800) on Mon. Oct. 10, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 27 | Latest Price | $101.5800(4.38%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.36% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-6%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
1 - 5 Day Possible Target | $87.51(-13.85%) | Resistance Level | $107.67 | 5 Day Moving Average | $99.86(1.72%) | 10 Day Moving Average | $100.68(0.89%) | 20 Day Moving Average | $107.67(-5.66%) | To recent high | -26.7% | To recent low | 4.4% | Market Cap | $1.632b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |